Inhaled statins to combat COVID-19 – prophylactic and treatment approach

Article Sidebar

PDF HTML
Submitted: May 25, 2020
Published: Jun 12, 2020
DOI: 10.29328/journal.ijcv.1001020
Crossref
Scopus
Google Scholar
Europe PMC

Main Article Content

Archana P Iyer
Department of Biochemistry, Science College, King Abdul Aziz University, Jeddah, Saudi Arabia
Maryam A Al-Ghamdi
Department of Biochemistry, Science College, King Abdul Aziz University, Jeddah, Saudi Arabia

Article Details

P Iyer, A., & A Al-Ghamdi, M. (2020). Inhaled statins to combat COVID-19 – prophylactic and treatment approach. International Journal of Clinical Virology, 4(1), 079–080. https://doi.org/10.29328/journal.ijcv.1001020
Review Articles

Copyright (c) 2020 Iyer AP, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis [published online ahead of print, 2020 Mar 31]. J Microbiol Immunol Infect. 2020; S1684-1182 (20) 30082-7. PubMed: https://pubmed.ncbi.nlm.nih.gov/32265180/

Hutchinson M, Tattersall RS, Manson JJ, Haemophagocytic lymphohisticytosis—an under recognized hyper inflammatory syndrome. Rheumatology. 2019; 58: vi23–vi30

Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506. PubMed: https://pubmed.ncbi.nlm.nih.gov/31986264/

Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The Lancet. 2020.

Derebail VK, Falk RJ. ANCA-associated vasculitis—refining therapy with plasma exchange and glucocorticoids. N Engl J Med. 2020; 382: 671-673. PubMed: https://pubmed.ncbi.nlm.nih.gov/32053306/